Truist Securities analyst Danielle Brill raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $110.00 (from $63.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE